27 results
8-K
EX-99.1
SMTI
Sanara MedTech Inc
30 Mar 22
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2021 Results
4:15pm
&D”) expenses. R&D expenses for the year ended December 31, 2021 were $0.6 million compared to $40,190 for the year ended December 31, 2020 … . The higher R&D expenses in 2021 were due to costs associated with several development projects for our currently licensed products and technologies.
Net income
8-K
EX-99.1
SMTI
Sanara MedTech Inc
15 May 23
Sanara MedTech Inc. Announces First Quarter 2023 Results
4:19pm
and development (“R&D”) expenses. R&D expenses for the three months ended March 31, 2023, were $1.3 million compared to $0.2 million for the three months ended … March 31, 2022. The higher R&D expenses in the three months ended March 31, 2023 were primarily due to costs related to the Precision Healing
8-K
EX-99.1
SMTI
Sanara MedTech Inc
14 Nov 22
Sanara MedTech Inc. Announces Third Quarter 2022 Results
4:40pm
of the Rochal Industries, LLC workforce in July 2021.
Research and development (“R&D”) expenses. R&D expenses for the three months ended September 30 … , 2022, were $1.1 million compared to $0.04 million for the three months ended September 30, 2021. R&D expenses for the nine months ended September 30
8-K
EX-99.1
SMTI
Sanara MedTech Inc
15 Aug 22
Sanara MedTech Inc. Announces Second Quarter 2022 Results
6:10pm
.
Research and development (“R&D”) expenses. R&D expenses for the three months ended June 30, 2022, were $1.1 million compared to $0.1 million … for the three months ended June 30, 2021. R&D expenses for the six months ended June 30, 2022, were $1.3 million compared to $0.2 million for the six months
8-K
EX-99.1
SMTI
Sanara MedTech Inc
16 May 22
Sanara MedTech Inc. Announces First Quarter 2022 Results
4:36pm
. As of March 31, 2022, we had a total of 31 field sales managers.
Research and development (“R&D”) expenses. R&D expenses for the three months ended March 31 … , 2022, were $0.20 million compared to $0.12 million for the three months ended March 31, 2021. The higher R&D expenses in 2022 were due to several
8-K
EX-99.1
t874c2z s91h
25 Mar 24
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
4:37pm
10QSB
zaqiylmd xl
23 May 05
Quarterly report (small business)
12:00am
10QSB
tb4jyhc0je
20 Dec 05
Quarterly report (small business)
12:00am